Hugh D. Riordan

2.3k total citations · 1 hit paper
30 papers, 1.7k citations indexed

About

Hugh D. Riordan is a scholar working on Nutrition and Dietetics, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Hugh D. Riordan has authored 30 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Nutrition and Dietetics, 8 papers in Pathology and Forensic Medicine and 6 papers in Molecular Biology. Recurrent topics in Hugh D. Riordan's work include Vitamin C and Antioxidants Research (19 papers), Vitamin D Research Studies (6 papers) and Retinoids in leukemia and cellular processes (3 papers). Hugh D. Riordan is often cited by papers focused on Vitamin C and Antioxidants Research (19 papers), Vitamin D Research Studies (6 papers) and Retinoids in leukemia and cellular processes (3 papers). Hugh D. Riordan collaborates with scholars based in United States, United Kingdom and Puerto Rico. Hugh D. Riordan's co-authors include Yaohui Wang, Stephen M. Hewitt, Mark Levine, Robert Wesley, Arie Katz, He Sun, Sebastian J. Padayatty, Neil H Riordan, Donald R. Davis and Melvin D. Epp and has published in prestigious journals such as Annals of Internal Medicine, British Journal of Cancer and The International Journal of Biochemistry & Cell Biology.

In The Last Decade

Hugh D. Riordan

29 papers receiving 1.6k citations

Hit Papers

Vitamin C Pharmacokinetic... 2004 2026 2011 2018 2004 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hugh D. Riordan United States 17 1.2k 477 308 225 161 30 1.7k
Abdullah Nabi Aslan Türkiye 19 329 0.3× 169 0.4× 219 0.7× 41 0.2× 100 0.6× 105 1.3k
Andrea M. Hutchins United States 23 694 0.6× 1.1k 2.2× 408 1.3× 88 0.4× 161 1.0× 53 2.2k
András Szarka Hungary 27 521 0.4× 188 0.4× 925 3.0× 67 0.3× 133 0.8× 72 2.8k
Katarzyna Socha Poland 27 459 0.4× 148 0.3× 302 1.0× 35 0.2× 161 1.0× 135 2.2k
Kyria Jayanne Clímaco Cruz Brazil 18 713 0.6× 110 0.2× 168 0.5× 40 0.2× 30 0.2× 54 1.4k
Jennifer Beatriz Silva Morais Brazil 16 563 0.5× 99 0.2× 192 0.6× 41 0.2× 31 0.2× 40 1.3k
Juliana Soares Severo Brazil 18 615 0.5× 113 0.2× 205 0.7× 41 0.2× 24 0.1× 58 1.4k
Anna P. Kipp Germany 35 1.7k 1.5× 170 0.4× 1.3k 4.2× 44 0.2× 151 0.9× 88 3.3k
Mevlüt Sait Keleş Türkiye 24 209 0.2× 135 0.3× 295 1.0× 48 0.2× 66 0.4× 82 1.8k
Caiying Zhang China 29 768 0.7× 77 0.2× 828 2.7× 93 0.4× 33 0.2× 117 2.3k

Countries citing papers authored by Hugh D. Riordan

Since Specialization
Citations

This map shows the geographic impact of Hugh D. Riordan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugh D. Riordan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugh D. Riordan more than expected).

Fields of papers citing papers by Hugh D. Riordan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hugh D. Riordan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugh D. Riordan. The network helps show where Hugh D. Riordan may publish in the future.

Co-authorship network of co-authors of Hugh D. Riordan

This figure shows the co-authorship network connecting the top 25 collaborators of Hugh D. Riordan. A scholar is included among the top collaborators of Hugh D. Riordan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hugh D. Riordan. Hugh D. Riordan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Riordan, Hugh D., et al.. (2012). The Effects of a Primary Nutritional Deficiency (Vitamin B study). Food and Nutrition Sciences. 3(9). 1238–1244. 8 indexed citations
2.
Casciari, Joseph J, Hugh D. Riordan, Jorge R. Miranda-Massari, & Michael J. González. (2005). Effects of high dose ascorbate administration on L-10 tumor growth in guinea pigs.. PubMed. 24(2). 145–50. 18 indexed citations
3.
González, Michael J., Jorge R. Miranda-Massari, Edna Mora, et al.. (2005). Orthomolecular Oncology Review: Ascorbic Acid and Cancer 25 Years Later. Integrative Cancer Therapies. 4(1). 32–44. 105 indexed citations
4.
Miranda-Massari, Jorge R., et al.. (2004). Intravenous ascorbic acid as a treatment for severe jellyfish stings.. PubMed. 23(2). 125–6. 4 indexed citations
5.
Padayatty, Sebastian J., He Sun, Yaohui Wang, et al.. (2004). Vitamin C Pharmacokinetics: Implications for Oral and Intravenous Use. Annals of Internal Medicine. 140(7). 533–537. 733 indexed citations breakdown →
6.
Park, Seyeon, Seong‐Su Han, Chan H. Park, et al.. (2004). l-Ascorbic acid induces apoptosis in acute myeloid leukemia cells via hydrogen peroxide-mediated mechanisms. The International Journal of Biochemistry & Cell Biology. 36(11). 2180–2195. 71 indexed citations
7.
Park, Seyeon, Chan H. Park, Eun‐Ryeong Hahm, et al.. (2004). Activation of Raf1 and the ERK pathway in response to l-ascorbic acid in acute myeloid leukemia cells. Cellular Signalling. 17(1). 111–119. 21 indexed citations
8.
Han, Seong‐Su, Kihyun Kım, Eun‐Ryeong Hahm, et al.. (2004). L‐ascorbic acid represses constitutive activation of NF‐κB and COX‐2 expression in human acute myeloid leukemia, HL‐60. Journal of Cellular Biochemistry. 93(2). 257–270. 38 indexed citations
9.
Davis, Donald R., Melvin D. Epp, & Hugh D. Riordan. (2004). Changes in USDA Food Composition Data for 43 Garden Crops, 1950 to 1999. Journal of the American College of Nutrition. 23(6). 669–682. 233 indexed citations
10.
Riordan, Neil H, Hugh D. Riordan, Nina Mikirova, et al.. (2004). Cell membrane fatty acid composition differs between normal and malignant cell lines.. PubMed. 23(2). 103–6. 29 indexed citations
11.
Mikirova, Nina, et al.. (2003). Detection of energy metabolism level in cancer patients by fluorescence emission from serum. 18(1). 9–24. 5 indexed citations
12.
James, Jackson, et al.. (2002). Sixteen-year history with high dose intravenous vitamin C treatment for various types of cancer and other diseases. 17(2). 117–119. 3 indexed citations
13.
González, Michael J., Hugh D. Riordan, & Jorge R. Miranda-Massari. (2002). Vitamin C and oxidative DNA damage revisited. 17(4). 225–228. 3 indexed citations
14.
Riordan, Neil H, Joseph J Casciari, Yan Zhu, et al.. (2002). Effects of a high molecular mass Convolvulus arvensis extract on tumor growth and angiogenesis.. PubMed. 21(4). 323–8. 22 indexed citations
15.
Casciari, Joseph J, Neil H Riordan, Thorsten Schmidt, et al.. (2001). Cytotoxicity of ascorbate, lipoic acid, and other antioxidants in hollow fibre in vitro tumours. British Journal of Cancer. 84(11). 1544–1550. 80 indexed citations
16.
Riordan, Neil H, et al.. (2000). Clinical and Experimental Experiences with Intravenous Vitamin C. 29 indexed citations
17.
Riordan, Hugh D., et al.. (1998). HIGH-DOSE INTRAVENOUS VITAMIN C IN THE TREATMENT OF A PATIENT WITH RENAL CELL CARCINOMA OF THE KIDNEY. 13(2). 72–73. 25 indexed citations
18.
González, Michael J., Neil H Riordan, & Hugh D. Riordan. (1998). Antioxidants as Chemopreventive Agents for Breast Cancer. 3 indexed citations
19.
Riordan, Neil H, et al.. (1995). Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agent. Medical Hypotheses. 44(3). 207–213. 86 indexed citations
20.
Jackson, James, et al.. (1991). Comparison of two cytotoxic food sensitivity tests.. PubMed. 10(2). 20–1.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026